Assessing Prenatal Exposure Risks to Microplastics and PFAS in Hawaii

The National Institutes of Health has committed $3.3 million through the National Institute of Environmental Health Sciences to a five-year University of Hawaiʻi at Mānoa study tracking how prenatal exposure to microplastics and per- and polyfluoroalkyl substances (PFAS) may shape early brain development, according to reporting from Maui Now. The project will follow 300 local families from the first trimester through the infant's first year, with assessments at 2, 6, and 12 months, making it one of the more tightly scheduled prospective cohorts in the current environmental-neurodevelopment portfolio.

Protocol structure and exposure variables

Co-leads Shiwen "Sherlock" Li, assistant professor and Chin Sik and Hyun Sook Chung Endowed Chair in the Thompson School of Social Work & Public Health's Department of Public Health Sciences, and Cassandra L. Hendrix, assistant professor in the Department of Psychology, have built the protocol around biomarker-validated exposure and repeated outcome measurement. Maternal blood samples, fetal ultrasound imaging, and cord blood and placenta tissue will be analyzed for PFAS and microplastic load. Li framed pregnancy and infancy as critical developmental windows when the brain is rapidly forming and may be especially vulnerable to environmental exposures, and Hendrix indicated that early, repeated assessments are designed to identify when, in development, these compounds first register measurable neurocognitive effects.

The cohort's site is itself an exposure variable. Prior research estimated Hawaiʻi per-capita seafood consumption at roughly 1.8 times the U.S. average, and North Pacific ocean currents concentrate microplastics along island shorelines and in marine life. The result is a higher-end exposure distribution than most mainland cohorts can offer, which improves statistical power for detecting small effect sizes while limiting the generalizability of point estimates to lower-exposure populations.

Relevance to preventive-policy analysis

The methodological architecture, built on biomarker-validated exposure, a defined vulnerability window, and serial developmental endpoints, mirrors the template epidemiologists have applied to long-contested neurotoxicant debates, including those over community water fluoridation. The UH Mānoa protocol does not measure fluoride, and no direct inference about fluoridation policy is supported by these data. What the study does provide is a worked example of how a regulatory science program can specify exposure thresholds, sample sizes, and outcome timing with enough precision to either confirm or rule out a small population-scale effect.

For analysts tracking the wider literature on environmental neurotoxicants and infant cognition, the variables worth monitoring are the published effect sizes at the 6- and 12-month endpoints, the confidence intervals around any reported associations, and whether the cohort produces a biomarker reference range other research groups can replicate in lower-exposure settings. None of those outputs is yet available; the study is in its baseline and recruitment phase, with first-wave follow-up data expected several years out.